Is CLSN or JEPQ a better dividend investment in 2026?

CLSN currently yields 102.74% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: CLSN offers higher current income.

What is the dividend yield difference between CLSN and JEPQ?

CLSN has a forward dividend yield of 102.74% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 91.64 percentage points.

Home › Compare › CLSN vs JEPQ

CLSN vs JEPQ: Dividend Comparison 2026

CLSN yields 102.74% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CLSN wins by $4.31M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CLSN

● Live price

102.74%

Share price

$1.95

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.36M

Annual income

$1,494,304.71

Full CLSN calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — CLSN vs JEPQ

📍 CLSN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CLSN	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CLSN + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CLSN pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLSN

Annual income on $10K today (after 15% tax)

$8,733.18/yr

After 10yr DRIP, annual income (after tax)

$1,270,159.00/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, CLSN beats the other by $1,268,329.30/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLSN + JEPQ for your $10,000?

CLSN: 50%JEPQ: 50%

100% JEPQ50/50100% CLSN

Portfolio after 10yr

$2.20M

Annual income

$748,228.64/yr

Blended yield

34.01%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CLSN right now

CLSN

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Altman Z

-7819.1

Piotroski

3/9

JEPQ

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLSN buys

JEPQ buys

No recent congressional trades found for CLSN or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCLSNJEPQ

Forward yield	102.74% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.36M	$44.8K ✓
Annual income after 10y	$1,494,304.71 ✓	$2,152.59
Total dividends collected	$3.90M	$16.3K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: CLSN vs JEPQ ($10,000, DRIP)

Year	CLSN Portfolio	CLSN Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$20,974	$10,274.32	$11,930	$1,110.39	+$9.0K → CLSN
2	$42,582	$20,139.91	$14,133	$1,224.34	+$28.4K → CLSN
3	$83,777	$38,213.45	$16,632	$1,340.46	+$67.1K → CLSN
4	$159,904	$70,262.72	$19,454	$1,457.97	+$140.4K → CLSN
5	$296,433	$125,336.27	$22,626	$1,576.08	+$273.8K → CLSN
6	$534,334	$217,150.75	$26,175	$1,694.09	+$508.2K → CLSN
7	$937,555	$365,816.85	$30,133	$1,811.32	+$907.4K → CLSN
8	$1,603,062	$599,878.65	$34,531	$1,927.17	+$1.57M → CLSN
9	$2,673,868	$958,591.11	$39,403	$2,041.08	+$2.63M → CLSN
10	$4,355,343	$1,494,304.71	$44,787	$2,152.59	+$4.31M → CLSN

CLSN vs JEPQ: Complete Analysis 2026

CLSN — Stock

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

Full CLSN Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this CLSN vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLSN vs SCHD CLSN vs JEPI CLSN vs O CLSN vs KO CLSN vs MAIN CLSN vs XYLD CLSN vs QYLD CLSN vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.